Health Care · Biotechnology

Innoviva, Inc. INVA

$21.30-0.14 (-0.65%)delayed quote · as of 2026-07-28 09:38 UTC

Open INVA in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$1.6B

Previous close

$21.44

Volume

591K

52-week range

$16.52 – $25.15

Verdictconfidence 60% · moderate

Solid footing across most dimensions.

3 of 5 dimensions score well. Value and Momentum not scored — not enough data.

Value—1/1 checks

Growth1003/3 checks

Quality1003/3 checks

Health1003/3 checks

Momentum—1/2 checks

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

—

P/E FWD

—

EV/EBITDA TTM

—

PEG

—

Growth

Revenue 3y

+7.5%/yr

Revenue YoY

+14.7%

Expected EPS

—

Quality

ROE

23.1%

Quality checks

bank measures

Health

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-28 09:38 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading INVA’s filed statements…

Continue with INVA in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.